Sign in

    Stefan Stalmann

    Senior Analyst at Autonomous Research

    Stefan Stalmann is a Senior Analyst at Autonomous Research specializing in European financial institutions, with a focus on Swiss, French, and German banks. He has actively covered major companies such as Deutsche Bank AG and Credit Agricole SA, participating in earnings call discussions and providing in-depth research for institutional clients. With a career in equity research beginning in 2000, Stalmann has developed extensive expertise in banking sector analysis and has been with Autonomous Research for over a decade, having previously held other roles in financial research. While detailed performance metrics and professional credentials such as securities licenses are not publicly listed, his long-standing industry presence and seniority highlight his stature as a recognized sector specialist.

    Stefan Stalmann's questions to DEUTSCHE BANK AKTIENGESELLSCHAFT (DB) leadership

    Stefan Stalmann's questions to DEUTSCHE BANK AKTIENGESELLSCHAFT (DB) leadership • Q2 2025

    Question

    Stefan Stalmann from Autonomous Research asked about Deutsche Bank's competitive position in capital markets, given the potential for U.S. banks to receive substantial capital relief. He also questioned the recurring positive contribution from valuation and timing differences in C&O, asking if the cumulative €2.5 billion benefit since 2018 is expected to reverse.

    Answer

    CEO Christian Sewing addressed competition by stating that European authorities are now more open to discussing the level playing field and that global clients increasingly seek a strong European alternative, which benefits Deutsche Bank. CFO James von Moltke explained the C&O gains are largely a 'pull to par' of derivative hedging losses from 2022-23, which will continue over time but with the near-term excess benefit washing out.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to DEUTSCHE BANK AKTIENGESELLSCHAFT (DB) leadership • Q1 2025

    Question

    Stefan Stalmann of Autonomous sought clarification on whether FIC trading was up year-on-year for the month of April or year-to-date. He also asked about the hedging of share-price-related compensation costs and the bank's U.S. dollar Net Stable Funding Ratio (NSFR).

    Answer

    CFO James von Moltke confirmed that FIC revenues were up year-on-year for both the month of April and year-to-date. He explained that while the group provides a hedge benefit to DWS on compensation, the expense impacts the consolidated group. Regarding the dollar NSFR, he stated the bank's position is very strong, with over 90% of dollar assets funded by dollar liabilities, and would be well over 100% including cross-currency funding.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to CREDIT AGRICOLE S A (CRARY) leadership

    Stefan Stalmann's questions to CREDIT AGRICOLE S A (CRARY) leadership • Q1 2025

    Question

    Stefan Stalmann of Autonomous Research inquired about the accounting treatment for the Banco BPM stake (fair value through P&L vs. equity), a discrepancy in the reported purchase of Crédit Agricole shares by regional banks, and the reason for a 12% decline in insurance distribution fees in regional banks.

    Answer

    Executive Jerome Grivet clarified that the 19.8% BPM stake is now split: half is accounted for through P&L (partially hedged) and the new half is accounted for through OCI (equity), not impacting P&L directly. He explained the regional banks' share purchase program of up to €500 million was not yet complete at quarter-end. The drop in insurance fees was attributed to a positive one-off base effect in Q1 2024; underlying fees actually grew around 7%.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to CREDIT AGRICOLE S A (CRARY) leadership • Q1 2025

    Question

    Stefan Stalmann asked about the accounting treatment for the Banco BPM stake, sought clarification on the regional banks' purchase of Crédit Agricole shares, and inquired about the reason for a decline in insurance distribution fees.

    Answer

    Executive Jerome Grivet explained that the Banco BPM stake is now accounted for in two parts: half through P&L (partially hedged) and the newer half through OCI. He clarified that the share purchase program by SAS Rue La Boétie was ongoing and not completed by quarter-end. The decline in insurance fees was attributed to a one-off positive adjustment in the prior year's quarter, with underlying fees actually growing about 7%.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to CREDIT AGRICOLE S A (CRARY) leadership • Q2 2024

    Question

    Stefan Stalmann from Autonomous Research questioned if recent net inflows into Eurolife policies signaled a permanent client shift and its potential solvency impact, and asked for clarification on the dividend accrual rate.

    Answer

    Executive Jerome Grivet explained that the dividend accrual is precisely 50% of the distributable result, with any perceived difference likely due to non-P&L items like AT1 coupon effects. Regarding insurance, he noted that higher rates have made Euro products more attractive, driving inflows, but the volume is modest and does not pose a threat to the solvency of the insurance business.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to Julius Baer Group (JBAXY) leadership

    Stefan Stalmann's questions to Julius Baer Group (JBAXY) leadership • H1 2023

    Question

    Stefan Stalmann from Autonomous Research inquired about the composition of the Lombard loan book, asking for the split between funds used for leveraged investments versus other purposes. He also questioned whether there was any regulatory appetite in Switzerland to change liquidity requirements like LCR and NSFR.

    Answer

    CFO Evie Kostakis estimated that approximately 80% of the Lombard book is used for reinvestment purposes. Regarding regulation, she stated there is currently no formal information on changes, but reforms are a reasonable expectation. She emphasized that Julius Baer, while not a too-big-to-fail bank, applies its own conservative liquidity stress tests, resulting in a high LCR of over 300%.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to Julius Baer Group (JBAXY) leadership • Q4 2022

    Question

    Stefan Stalmann requested clarification on the 'other factors' benefit in the CET1 waterfall and asked for color on the reduction in client deposits since June, questioning if it was due to disintermediation and if the trend would continue.

    Answer

    CFO Evie Kostakis directed the question on CET1 details to an appendix slide. Regarding deposits, she noted a significant FX translation effect on the decline and commented that future trends are hard to predict, as Julius Bär is often seen as a 'Safe Harbor' for deposits in risk-off environments.

    Ask Fintool Equity Research AI

    Stefan Stalmann's questions to Julius Baer Group (JBAXY) leadership • Q4 2015

    Question

    Stefan Stalmann of Autonomous Research asked about the practicality of the 11% CET1 target, the strategic ambitions for the new investment management division, and the potential for legal liabilities beyond the resolved U.S. case.

    Answer

    CFO Dieter Enkelmann explained the firm would only consider going below the 11% CET1 target for a large acquisition, with the regulatory minimum as an absolute floor. He also stated that provisions are taken for likely legal cases, and the other disclosed cases are viewed as less likely to result in payment. CEO Boris Collardi clarified the new division is a spin-off of an internal unit to sharpen focus on investment performance for Julius Baer's clients, not a return to third-party asset management.

    Ask Fintool Equity Research AI